Medicare Enrolled
Dr. Angelo Illuzzi, DO
Pulmonary Disease · Du Bois, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Illuzzi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Illuzzi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Illuzzi
Dr. Angelo Illuzzi is a pulmonary disease specialist in Du Bois, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Illuzzi performed 1,191 Medicare services across 1,070 unique beneficiaries.
Between the years covered by Open Payments, Dr. Illuzzi received a total of $6,899 from 46 pharmaceutical and/or device companies across 361 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Illuzzi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 20% volume in PA
$6,899 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,191
Medicare services
Top 20% in PA for pulmonary disease
1,070
Unique beneficiaries
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~63 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
361 | $43 | $68 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
205 | $67 | $100 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
151 | $7 | $40 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
109 | $6 | $37 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
107 | $8 | $37 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
100 | $30 | $348 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
52 | $82 | $450 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
33 | $55 | $120 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
21 | $100 | $136 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
15 | $86 | $420 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
13 | $16 | $50 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function. |
13 | $32 | $130 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
11 | $39 | $75 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,899
Total received (2018-2024)
Avg $986/year across 7 years
Top 24% in PA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
361
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,485 (94.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$414 (6.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,611
2023
$1,375
2022
$1,149
2021
$690
2020
$425
2019
$675
2018
$972
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$339
Inspire Medical Systems, Inc.
$188
HARMONY BIOSCIENCES LLC
$146
GlaxoSmithKline, LLC.
$143
AstraZeneca Pharmaceuticals LP
$114
INTUITIVE SURGICAL, INC.
$101
SANOFI-AVENTIS U.S. LLC
$79
Avadel CNS Pharmaceuticals, LLC
$61
United Therapeutics Corporation
$59
JAZZ PHARMACEUTICALS INC.
$35
Regeneron Healthcare Solutions, Inc.
$33
Resmed Corp
$32
Axsome Therapeutics, Inc.
$30
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
ABBVIE INC.
$24
Philips North America LLC
$24
Mallinckrodt Hospital Products Inc.
$22
ZOLL Respicardia, Inc.
$21
Pharming Healthcare, Inc.
$20
Amgen Inc.
$19
Actelion Pharmaceuticals US, Inc.
$18
Insmed, Inc.
$18
Baxter Healthcare
$17
PFIZER INC.
$16
Grifols USA, LLC
$14
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$9
Top 3 companies account for 41.8% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$740
GlaxoSmithKline, LLC.
$728
Actelion Pharmaceuticals US, Inc.
$719
GENZYME CORPORATION
$600
Boehringer Ingelheim Pharmaceuticals, Inc.
$372
Inspire Medical Systems, Inc.
$358
JAZZ PHARMACEUTICALS INC.
$280
Regeneron Healthcare Solutions, Inc.
$252
Philips Electronics North America Corporation
$248
HARMONY BIOSCIENCES LLC
$187
PFIZER INC.
$180
SANOFI-AVENTIS U.S. LLC
$179
Harmony Biosciences LLC
$175
Resmed Corp
$148
Grifols USA, LLC
$134
Mylan Specialty L.P.
$133
Janssen Pharmaceuticals, Inc
$114
Axsome Therapeutics, Inc.
$107
INTUITIVE SURGICAL, INC.
$101
Circassia Pharmaceuticals Inc
$93
Baxter Healthcare
$87
Sunovion Pharmaceuticals Inc.
$86
Insmed, Inc.
$85
Takeda Pharmaceuticals U.S.A., Inc.
$78
Amgen Inc.
$75
Novartis Pharmaceuticals Corporation
$73
Gilead Sciences, Inc.
$67
Avadel CNS Pharmaceuticals, LLC
$61
United Therapeutics Corporation
$59
Jazz Pharmaceuticals Inc.
$53
Merck Sharp & Dohme LLC
$32
Haemonetics Corporation
$31
Paratek Pharmaceuticals, Inc.
$26
ABBVIE INC.
$24
Philips North America LLC
$24
Mallinckrodt Hospital Products Inc.
$22
ZOLL Respicardia, Inc.
$21
E.R. Squibb & Sons, L.L.C.
$21
Pharming Healthcare, Inc.
$20
ADVANCED RESPIRATORY, INC
$19
Otsuka America Pharmaceutical, Inc.
$17
Advanced Respiratory, Inc
$16
Merck Sharp & Dohme Corporation
$16
Exeltis, USA Inc.
$16
Mallinckrodt LLC
$12
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$9
Top 3 companies account for 31.7% of all-time payments
Associated products mentioned in payments ›
(2535) Sleep Service · (8744) Trilogy Evo · (8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSENSE · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · ASMANEX · Arikayce · Astral · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · CHANTIX · DIFICID · DUPIXENT · Da Vinci Surgical System · DreamWear Full · ELIQUIS · FASENRA · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · INSPIRE · Inspire Upper Airway Stimulation System · LONHALA MAGNAIR · LUMRYZ · LifeVest · NUCALA · NUZYRA · OFEV · OPDIVO · OPSUMIT · OPSUMIT MACITENTAN · PREVNAR - 13 · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Prolastin-C · Prolastin-C Liquid · RUCONEST · SAMSCA · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEFLARO · TEG · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · WAKIX · Wakix · Wellcentive Undiv · XARELTO · XOLAIR · XYREM · XYWAV · Xyrem · YUPELRI · Yupelri · remede System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
3
Per 100K population
3.8
County median income
$60,181
Nearest hospital
PENN HIGHLANDS DUBOIS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Illuzzi is a clinical cardiology specialist, with above-average Medicare volume (top 20% in PA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Illuzzi experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Illuzzi performed 361 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Illuzzi receive payments from pharmaceutical companies?
Yes. Dr. Illuzzi received a total of $6,899 from 46 companies across 361 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Illuzzi's costs compare to other pulmonary diseases in Du Bois?
Dr. Illuzzi's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Illuzzi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Du Bois
Browse pulmonary diseases in Du Bois ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in PA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in PA
Which PA pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Actelion Pharmaceuticals US, Inc. Payments to Doctors
See all physicians who received payments from Actelion Pharmaceuticals US, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology